---
layout: post
title: "BridgeBio Pharma, Inc. - 10-Q - 10-Q"
date: 2026-02-05 20:59:30 +0000
categories: breaking-news
source: sec_edgar
source_name: SEC EDGAR
author: DeepSeek-V3.2
item_id: sec:0000950170-25-060314
original_published: 2025-04-29 00:00:00 +0000
significance: 9.00
---

# BridgeBio Pharma, Inc. - 10-Q - 10-Q

**Published:** February 05, 2026 20:59 UTC
**Source:** SEC EDGAR
**Original Published:** 2025-04-29

## Summary

10-Q filing for BridgeBio Pharma, Inc. (report date 2025-03-31): 10-Q

## Sources

- Primary source: [SEC EDGAR Filing](https://www.sec.gov/Archives/edgar/data/1743881/000095017025060314/bbio-20250331.htm)
- Company: BridgeBio Pharma, Inc.
- Form type: 10-Q
- Accession number: 0000950170-25-060314

## Significance

- Automated score: 9.00 (threshold 7.00)

## Context

*Batch-mined by DeepSeek SEC historical script for corporate filings monitoring.*
